Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

COVID-19 in Polish Ice Swimmers. (ICE)

6 de abril de 2021 actualizado por: Wroclaw Medical University

Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.

Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.

The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.

Tipo de estudio

De observación

Inscripción (Actual)

2534

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

  • Polonia
    • Dolny Slask
      • Wrocław, Dolny Slask, Polonia, 51-618
        • Department of Public Health at Wroclaw Medical University
    • Lubuskie
      • Gorzów Wielkopolski, Lubuskie, Polonia, 66-400
        • Department of Radiotherapy of Multidisciplinary Provincial Hospital
      • Zielona Góra, Lubuskie, Polonia, 65-031
        • Treasury Medical Company

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Surveys are distributed en masse among ice swimmers from Poland. Comparative data for the control group is derived from officially published national and regional pandemic data.

Descripción

Inclusion Criteria:

  • ice swimmers

Exclusion Criteria:

  • not active ice swimmers

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Ice Swimmers Group.
No intervention. Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
Otro: Ice Swimming
The intervention is not made in the course of a research study. Ice swimming has been introduced earlier by a given group. The group was made up of people who already swim in ice.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Periodo de tiempo: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Periodo de tiempo: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Periodo de tiempo: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Periodo de tiempo: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Periodo de tiempo: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Periodo de tiempo: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Periodo de tiempo: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Wroclaw Medical University

Investigadores

  • Director de estudio: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
  • Director de estudio: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
  • Silla de estudio: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
  • Investigador principal: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
  • Investigador principal: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de diciembre de 2020

Finalización primaria (Actual)

17 de enero de 2021

Finalización del estudio (Actual)

1 de marzo de 2021

Fechas de registro del estudio

Enviado por primera vez

24 de marzo de 2021

Primero enviado que cumplió con los criterios de control de calidad

25 de marzo de 2021

Publicado por primera vez (Actual)

26 de marzo de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de abril de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

6 de abril de 2021

Última verificación

1 de abril de 2021

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • KB-03/139/2021

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir